CSE

Sponsor/Director

Govt.

Institute

Foreign

Public

As on 31-Aug, 2021

34.57

0

13.97

14.59

36.87

As on 31-Jul, 2021

34.57

0

13.86

14.69

36.88

As on 31-May, 2021

34.57

0

13.38

15.53

36.52

As on 30-Jun, 2021 (year ended)

34.57

0

13.45

15.27

36.71

Remarks
Note

Half Year End (HY) Information

202012

HY Net Turnover(mn)

24941.64

HY Net Profit after tax(mn)

7769.60

HY EPS

8.76

AGM Information

AGM Date

15 December, 2020

Record Date

22 November, 2020

Dividend(%)

52.00 (47% Cash &5% Stock)

Bonus Issue

5% 2020,7% 2019,7% 2018,7.5% 2017, 10% 2016, 12.50% 2015, 15% 2014, 30% 2013, 40% 2012, 35% 2011, 30% 2010, 25% 2009, 35% 2008, 50% 2007, 20 06, 15% 2005, 20% 2004

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
Performance Year	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income	Net Asset Value Per Share	Restated Net Asset Value Per Share	Continuous operations	Including Extra-Ordinary Income	% Dividend	% Dividend Yield
2020	15.82	0	0	0	91.57	0	13354.41	0	47%C,5%B	2.72
2019	16.03	0	0	0	86.03	0	12645.72	0	42%C,7%B	1.59
2018	15.72	0	0	0	78.41	0	11593.96	0	36%C,7%B	1.23
2017	15.51	0	0	0	71.47	0	10637.22	0	35%C,7.5%B	1.21
2016	3.84	0	0	0	0	0	2394.58	2385.42	-	0


Financial Statements
Quarterly Financial Statement	http://www.squarepharma.com.bd/quarterly-reports.php

Price Sensitive Information

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph

Form	To

Stock Broker

IPO

QIO

Services

Rules & Regulations

Trading

Strategic Partners

Useful Links